The risk of developing multiple myeloma (a form of blood cancer) increases in patients with monoclonal gammopathy of undetermined significance (MGUS) even after 30 years of stability. MGUS is a condition in which an abnormal protein, known as monoclonal protein or M protein, is found in the blood.
MGUS normally do not cause problems, but may sometimes progress into multiple myeloma. The study was led by Mayo Clinic research team and the findings are published in New England Journal of Medicine.
Multiple Myeloma
Multiple Myeloma caught public attention when model turned actress Lisa Ray, who worked in Deepa Mehta's 'Water' , declared that she had the incurable Multiple Myeloma.
Advertisement
‘Patients with MGUS who develop multiple myeloma may have a shorter survival than people without the condition.’
Tweet it Now
"Monoclonal gammopathy of undetermined significance is present in more than 3 percent of the general population age 50 and older," says S. Vincent Rajkumar, M.D., a hematologist at Mayo Clinic and senior author of the study. "In some cases, people with monoclonal gammopathy of undetermined significance go on to develop multiple myeloma."
In their study, Dr. Rajkumar and his colleagues found that the overall risk of progression to myeloma or a related disorder is relatively small at 1 percent each year; however, the risk persists indefinitely. Scientists also noted that risk of myeloma or related cancer was relatively small, compared to other general causes of death. As a result, they recommend that patients who are followed for monoclonal gammopathy of undetermined significance not only be checked for presence or absence of progression, but also receive all other routine preventive services appropriate for patients as they age.
![New Therapeutic Approach can Help Treat Multiple Myeloma]( "New Therapeutic Approach can Help Treat Multiple Myeloma")
Multiple myeloma is a cancer that grows in bone, and in most patients it is associated with widespread bone loss, and recurrent bone fractures.
"We also found that patients with monoclonal gammopathy of undetermined significance had shorter survival than comparable people without the condition," says Dr. Rajkumar, which raises the possibility there may be other disorders associated with monoclonal gammopathy of undetermined significance that still need further study."
Research team studied 1,384 patients with two major types of monoclonal gammopathy of undetermined significance: IgM monoclonal gammopathy of undetermined significance and non-IgM monoclonal gammopathy of undetermined significance, and associated risk factors health professional use to counsel patients.
Source: Eurekalert
New Therapeutic Approach can Help Treat Multiple Myeloma
Multiple myeloma is a cancer that grows in bone, and in most patients it is associated with widespread bone loss, and recurrent bone fractures.
Advertisement
"We also found that patients with monoclonal gammopathy of undetermined significance had shorter survival than comparable people without the condition," says Dr. Rajkumar, which raises the possibility there may be other disorders associated with monoclonal gammopathy of undetermined significance that still need further study."
Research team studied 1,384 patients with two major types of monoclonal gammopathy of undetermined significance: IgM monoclonal gammopathy of undetermined significance and non-IgM monoclonal gammopathy of undetermined significance, and associated risk factors health professional use to counsel patients.
Source: Eurekalert
Novel Method May Help Doctors Choose Cancer Drugs
Doctors have many drugs available to treat multiple myeloma, but there is no way to predict how a patient will respond to a particular drug.
Advertisement
 Progression Towards Multiple Myeloma IdentifiedThe biology of multiple myeloma, a cancer of plasma cells has been explained and how it changes from asymptomatic stages to symptomatic later. | Advertisement
|
Advertisement
Recommended Reading
Latest Cancer News
The first large-scale, collaborative, open analysis of genomic data provides a cloud-based resource for researchers looking for more comprehensive data on pediatric brain tumors.
The mission of Axiom Space incorporated numerous experiments focusing on human stem cell aging, inflammation, and cancer within the laboratory situated in the low Earth orbit.
Providing a sustained supply of hydrogen sulfide to cancer cells, could be a remodeling strategy to improve photothermal therapy efficacy while minimizing side effects.
Colon cancer's hidden link revealed in microbiome study.
Breast cancer patients in the obese or overweight category can greatly benefit from a telephone-based weight management program in achieving significant weight loss.